One Health Company Collaborates with IDEXX to Expand Access to FidoCure® Precision Medicine Platform
January 13, 2022 at 12:06 pm EST
Share
One Health Company announced a collaboration with IDEXX Laboratories, Inc. IDEXX Reference Laboratories will offer the FidoCure Next Generation DNA Sequencing Test to its veterinary customers in the United States and Canada later this month. The collaboration, which expands IDEXX's cancer care management portfolio, further enables veterinarians to deliver personalized care to their cancer patients by expanding access to FidoCure's precision medicine platform.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows:
- veterinary diagnoses for pets (90.8%);
- water quality analysis (4.6%);
- veterinary diagnoses for livestock and poultry (4.2%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products;
- other (5.5%).
Net sales by source of income break down between product sales (57.3%) and services (42.7%).
Net sales are distributed geographically as follows: the United States (64.8%), Americas (6.5%), Germany (4.1%), the United Kingdom (3.2%), France (2.5%), Italy (1.4%), Spain (1.4%), Switzerland (0.9%), Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.9%), Japan (2 .3%), China (1.5%) and Asia/Pacific (2.9%).